Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
VWE - Vintage Wine Estates Inc - Stock Price Chart
TickerVWE [NASD]
CompanyVintage Wine Estates Inc
CountryUSA
IndustryBeverages - Wineries & Distilleries
Market Cap4.18MEPS (ttm)-2.32
P/E-EPS this Y19.44%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B0.05EPS Q/Q-154.73%
Dividend-Sales Q/Q-34.27%
Insider Own45.35%Inst Own14.48%
Insider Trans0.00%Inst Trans-6.66%
Short Float0.66%EarningsMar 12/a
Analyst Recom1.00Target Price1.00
Avg Volume1.68M52W Range0.06 - 1.05
XAUG - FT Vest U.S. Equity Enhance & Moderate Buffer ETF - August - Stock Price Chart
TickerXAUG [AMEX]
CompanyFT Vest U.S. Equity Enhance & Moderate Buffer ETF - August
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, SP500, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings7AUM11.54M
Flows% 1M-6.67%Flows% 3M-17.57%
Flows% YTD-45.54%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume1.52K52W Range29.05 - 33.03
RGC - Regencell Bioscience Holdings Ltd - Stock Price Chart
TickerRGC [NASD]
CompanyRegencell Bioscience Holdings Ltd
CountryHong Kong
IndustryDrug Manufacturers - Specialty & Generic
Market Cap159.89MEPS (ttm)-0.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-95.48%
P/S-EPS next 5Y-
P/B15.74EPS Q/Q35.97%
Dividend-Sales Q/Q-
Insider Own7.60%Inst Own0.01%
Insider Trans0.00%Inst Trans-
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume69.77K52W Range3.03 - 32.44
AUGZ - TrueShares Structured Outcome (August) ETF - Stock Price Chart
TickerAUGZ [AMEX]
CompanyTrueShares Structured Outcome (August) ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexS&P 500 Index
TagsU.S., options, buffer, upside-cap, fixed-period, SP500
Sector/Theme Region
Dividend3.06%Active/Passive
Total Holdings4AUM15.63M
Flows% 1M0.00%Flows% 3M0.00%
Flows% YTD-8.36%Flows% 1Y
Return% 1Y15.10%Return% 3Y0.07%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume0.72K52W Range31.71 - 39.19
TIVC - Tivic Health Systems Inc - Stock Price Chart
TickerTIVC [NASD]
CompanyTivic Health Systems Inc
CountryUSA
IndustryMedical Devices
Market Cap2.79MEPS (ttm)-11.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y30.58%
P/S2.47EPS next 5Y-
P/B0.31EPS Q/Q90.41%
Dividend-Sales Q/Q-11.17%
Insider Own0.34%Inst Own1.09%
Insider Trans0.00%Inst Trans-70.81%
Short Float0.22%EarningsMay 15/a
Analyst Recom-Target Price-
Avg Volume1.87M52W Range0.28 - 11.46
CGTX - Cognition Therapeutics Inc - Stock Price Chart
TickerCGTX [NASD]
CompanyCognition Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap94.94MEPS (ttm)-0.92
P/E-EPS this Y-7.56%
Forward P/E-EPS next Y-14.05%
PEG-EPS past 5Y-21.09%
P/S-EPS next 5Y-
P/B3.28EPS Q/Q-27.91%
Dividend-Sales Q/Q-
Insider Own15.81%Inst Own17.83%
Insider Trans0.09%Inst Trans-0.77%
Short Float0.64%EarningsMay 07/b
Analyst Recom1.00Target Price9.80
Avg Volume155.81K52W Range0.90 - 2.95
Today 04:11PM Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at 8:30am ET on Monday July 29, 2024 (GlobeNewswire) +12.86%
Jul-02-24 07:30AM Results from Cognition Therapeutics' Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease Accepted for Presentation at AAIC (GlobeNewswire) +8.98%
May-21-24 07:30AM Cognition Therapeutics Releases New Episode of Conversations Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease (GlobeNewswire) +8.10%
May-07-24 01:53PM CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update (GlobeNewswire)
Apr-29-24 07:30AM Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies (GlobeNewswire)
Apr-22-24 07:30AM Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease (GlobeNewswire)
Apr-02-24 07:30AM Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 07:30AM Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 (GlobeNewswire)
Mar-27-24 09:31AM Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
SAUG - FT Vest U.S. Small Cap Moderate Buffer ETF - August - Stock Price Chart
TickerSAUG [AMEX]
CompanyFT Vest U.S. Small Cap Moderate Buffer ETF - August
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexiShares Russell 2000 ETF
TagsU.S., options, SP500, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings6AUM41.38M
Flows% 1M-0.14%Flows% 3M-0.14%
Flows% YTD2.22%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume5.03K52W Range18.70 - 23.16
EVRI - Everi Holdings Inc - Stock Price Chart
TickerEVRI [NYSE, RUT]
CompanyEveri Holdings Inc
CountryUSA
IndustryGambling
Market Cap1.08BEPS (ttm)0.66
P/E19.47EPS this Y-23.45%
Forward P/E13.73EPS next Y34.01%
PEG0.97EPS past 5Y40.40%
P/S1.34EPS next 5Y20.00%
P/B4.65EPS Q/Q-82.37%
Dividend1.52%Sales Q/Q-6.64%
Insider Own3.77%Inst Own84.86%
Insider Trans-5.11%Inst Trans-1.68%
Short Float5.09%EarningsMay 08/b
Analyst Recom2.33Target Price11.54
Avg Volume1.64M52W Range6.37 - 15.25
GINN - Goldman Sachs Innovate Equity ETF - Stock Price Chart
TickerGINN [NYSE]
CompanyGoldman Sachs Innovate Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Factor & Thematic
IndexSolactive Innovative Global Eq Indx
TagsGlobal, equity, technology, innovation, big-data
Sector/Theme Region
Dividend0.93%Active/Passive
Total Holdings480AUM349.53M
Flows% 1M-0.83%Flows% 3M-2.40%
Flows% YTD-9.16%Flows% 1Y
Return% 1Y12.71%Return% 3Y-0.02%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume6.82K52W Range43.43 - 59.93
DXCM - Dexcom Inc - Stock Price Chart
TickerDXCM [NASD, NDX, S&P 500]
CompanyDexcom Inc
CountryUSA
IndustryMedical Devices
Market Cap25.45BEPS (ttm)1.62
P/E39.44EPS this Y11.96%
Forward P/E31.65EPS next Y18.83%
PEG2.18EPS past 5Y-
P/S6.47EPS next 5Y18.05%
P/B10.53EPS Q/Q26.60%
Dividend-Sales Q/Q15.26%
Insider Own1.55%Inst Own94.12%
Insider Trans-3.55%Inst Trans-0.34%
Short Float2.66%EarningsJul 25/a
Analyst Recom1.63Target Price102.90
Avg Volume2.85M52W Range74.75 - 142.00
TodayDowngrade JP Morgan Overweight → Neutral $145 → $75
TodayDowngrade Robert W. Baird Outperform → Neutral $161 → $80
12345671020